Independent Validation of a HER2-Low Focused Immunohistochemistry Scoring System for Enhanced Pathologist Precision and Consistency
Modern Pathology · 2025-04 · 38 (4) · 100693
DOI: 10.1016/j.modpat.2024.100693 ↗Kurz gefasst
Validierungsstudie in der Zeitschrift Modern Pathology, 2025-04. Verfasst von Gelareh Farshid und 8 weiteren Autor:innen. Beteiligte Einrichtung: Discipline of Medicine, Adelaide University, Adelaide, Australia; Directorate of Anatomical Pathology, SA Pathology, Royal Adelaide Hospital, Adelaid…. Hauptthemen laut MEDLINE: Erb-b2 Receptor Tyrosine Kinases, Breast Neoplasms, Immunohistochemistry, Biomarkers, Tumor. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 23 Literaturangaben. Gefördert von: AstraZeneca Australia.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Discipline of Medicine, Adelaide University, Adelaide, Australia; Directorate of Anatomical Pathology, SA Pathology, Royal Adelaide Hospital, Adelaide, Australia. Electronic address: gelareh.farshid2@sa.gov.au.
- Sullivan Nicolaides Pathology, Birtinya, Queensland, Australia.
- Clinipath Pathology, A Division of Sonic Healthcare Australia Pathology, Osborne Park, Australia; Pathology and Laboratory Medicine, Medical School, Perth, Australia.
- Directorate of Anatomical Pathology, SA Pathology, Royal Adelaide Hospital, Adelaide, Australia.
- Monash Health Pathology, Anatomical Pathology and Diagnostic Genomics, Monash Health, Melbourne, Victoria, Australia.
- NSW Health Pathology, Department of Anatomical Pathology, St George Hospital, Kogarah, Australia; School of Clinical Medicine, UNSW Medicine & Health, Sydney, Australia.
Förderung
- AstraZeneca Australia
Zitieren
APA
Farshid, G., Armes, J., Dessauvagie, B., Gilhotra, A., Kumar, B., Mahajan, H., Millar, E., Pathmanathan, N., & Snell, C. (2025). Independent Validation of a HER2-Low Focused Immunohistochemistry Scoring System for Enhanced Pathologist Precision and Consistency. Modern Pathology, 38(4), 100693. https://doi.org/10.1016/j.modpat.2024.100693
Vancouver
Farshid G, Armes J, Dessauvagie B, Gilhotra A, Kumar B, Mahajan H, et al. Independent Validation of a HER2-Low Focused Immunohistochemistry Scoring System for Enhanced Pathologist Precision and Consistency. Modern Pathology. 2025;38(4):100693. doi:10.1016/j.modpat.2024.100693
BibTeX
@article{Farshid2025,
author = {Farshid, Gelareh and Armes, Jane and Dessauvagie, Benjamin and Gilhotra, Amardeep and Kumar, Beena and Mahajan, Hema and Millar, Ewan and Pathmanathan, Nirmala and Snell, Cameron},
title = {Independent Validation of a HER2-Low Focused Immunohistochemistry Scoring System for Enhanced Pathologist Precision and Consistency},
journal = {Modern Pathology},
year = {2025},
volume = {38},
number = {4},
pages = {100693},
doi = {10.1016/j.modpat.2024.100693}
}
EUVIMED